The honest balance between the two
Potential advantages
- NEO's fat indication is the one part of the range for which regulators actually reviewed clinical data, and that study recorded an average abdominal circumference reduction of 3.2 cm at three months
- The only sham-controlled randomised trial in this whole field tested NEO and was positive: abdominal fat thickness fell 28.3 per cent and abdominal muscle thickness rose 24.2 per cent at three months, with no change in the sham group
- Neither device breaks the skin, sessions last half an hour, and across systematic reviews adverse events are consistently described as few or absent
Limitations and trade-offs
- The muscle claims both devices share were cleared with no clinical testing at all, in the regulator's own words, so 'FDA cleared' tells you nothing about whether muscle building was ever demonstrated
- Almost the entire published efficacy literature is written by paid advisors to the manufacturer, and a review that graded 20 studies rated none of them high quality
- In millimetres rather than percentages the pooled changes are small, around 8.0 mm of fat and 5.5 mm of muscle for the NEO platform, and independent reviewers question whether that is clinically meaningful
EMSculpt and EMSculpt NEO sit side by side on the same price list in a lot of clinics, and the names imply a straightforward upgrade. The real difference is narrower and much more useful than “newer is better”. NEO pushes a second kind of energy through the same applicator at the same time, and that single addition is why the two machines carry different claims, rest on different evidence, and rule out different people.
The short version
| EMSculpt | EMSculpt NEO | |
|---|---|---|
| Energy delivered | Pulsed electromagnetic field (HIFEM) alone | HIFEM plus bipolar radiofrequency at 27.12 MHz, together |
| Intended effect | Contract muscle | Contract muscle and heat fat |
| US clearance wording | Improvement of abdominal tone, strengthening of the abdominal muscles, firmer abdomen; toning of buttocks, thighs, arms and calves | The same muscle wording, plus non-invasive lipolysis and circumference reduction of the abdomen |
| Clinical data behind that clearance | None for the muscle indications | Yes, for the fat indication |
| Typical course | 4 sessions, 2 to 3 days apart | 3 weekly sessions in the pivotal study |
| Best suited to | A fat layer of roughly 2 to 3 cm or less | Marketed up to BMI 35, though the arm clearance caps at BMI 30 |
What the original EMSculpt does
EMSculpt applies a rapidly changing magnetic field over a muscle group. By induction that field creates a current in the tissue beneath, and when the current crosses the threshold at which motor neurons fire, the muscle contracts whether you intend it to or not. Because the stimulus bypasses voluntary control, the contraction is described as supramaximal: larger than you could produce yourself, and held without the usual relaxation phase.
The numbers in the regulatory file are specific. Peak magnetic flux density runs from 0.5 to 2.5 tesla depending on the applicator, and pulses repeat at 1 to 150 Hz. Effective penetration of the large applicator is around 7 cm, and field strength falls away quadratically with distance. That physics is why candidacy matters: a thick fat layer can leave the contractions weak or, in the manufacturer-aligned literature’s phrase, none or very mild.
What EMSculpt does not do is anything to fat. There is no fat indication anywhere in its clearances, and an independent study funded by a competing manufacturer found no loss of fat cell viability in human biopsies after electromagnetic muscle stimulation, while cryolipolysis controls in the same study showed clear irreversible injury. That paper carries its own conflict of interest and should be read as contested, not settled, but it belongs in the picture.
What NEO adds
NEO keeps the electromagnetic field and layers bipolar radiofrequency on top, at 27.12 MHz with a maximum total output of 60 watts across two channels, capped at 30 minutes. The stated mechanism is bulk heating of the fat layer to a temperature at which fat cells die. The regulatory submission records target tissue temperatures of 40 to 43 degrees Celsius; a manufacturer-funded human histology study reports 42 to 45 degrees and a fall in adipocyte count of about a third.
The two therefore feel different: NEO’s applicator warms noticeably as the contractions run.
Two claims, two entirely separate clearances
This is the part clinics rarely explain, and the most useful thing to understand before you spend anything.
The muscle claims and the fat claims are legally separate in the United States. Muscle sits under one regulation as a powered muscle stimulator; fat sits under a completely different one and needed its own submission with its own study. The muscle clearance, granted in 2017, states plainly that the substantial equivalence determination was not based on clinical testing. No trial of muscle building was reviewed. That is ordinary for this route, which compares a new device to an existing one rather than testing it, but it means “FDA cleared” is not evidence that the toning claim was demonstrated.
The fat clearance is different. It required data: 44 subjects enrolled, 42 completed, three treatments, and at three months an average abdominal circumference reduction of 3.2 cm, with 88.1 per cent achieving at least 1.5 cm and an ultrasound fat layer reduction of 29.8 per cent. Muscle soreness was reported by 11 of those subjects. So if you are being sold NEO for fat, that claim rests on reviewed clinical data. If you are being sold either device for muscle, it does not.
Neither term travels to the UK: American clearance has no legal standing here. Both platforms are regulated as medical devices under the Medical Devices Regulations 2002, and devices placed on the UK market must be registered with the MHRA, which is an administrative step rather than a verdict on whether anything works.
Does NEO actually outperform EMSculpt?
Probably, on the published figures, with a large caveat attached to all of them.
The strongest study in the entire field tested NEO: a sham-controlled randomised trial of 72 patients, three weekly abdominal sessions, ultrasound at one, three and six months. At three months abdominal fat thickness had fallen 28.3 per cent and rectus abdominis thickness had risen 24.2 per cent, gains held at six months, and the sham group changed in neither. Nothing comparable exists for the original device.
The only useful head to head compared the two directly on buttocks in 67 patients: muscle thickness rose 24.7 per cent with radiofrequency added, against 15.9 per cent without it.
Now the caveats, and they are substantial. Independent reviewers found that all seven studies of the NEO platform were authored by advisors to the manufacturer, and that almost all studies of the original device were too. A review that graded 20 studies covering 521 patients rated none of them high quality: nine moderate, eight low, three very low. And the same independent reviewers convert the percentages back into millimetres, which is where the enthusiasm cools: pooled, the electromagnetic field alone shifts about 5.5 mm of fat and 2.2 mm of muscle, and the combined platform about 8.0 mm and 5.5 mm. They argue those changes sit close to the margin of error. Whether a few millimetres matters to you is a judgement, but make it with the millimetres in front of you rather than the percentages. We look at that argument in more detail in our piece on whether the fat claim holds up independently.
The published evidence is also almost entirely abdominal. The graded review concluded the technology works for abdominal contouring for up to a year, while stating that larger controlled studies are needed for buttocks, thighs, arms and calves. The whole published calf evidence base is two patients.
Where Scotland stands on both
Here the two devices genuinely diverge, and the position differs from most national articles.
Scotland is bringing a named list of non-surgical procedures into licensing through the Civic Government (Scotland) Act 1982 (Licensing of Non-surgical Procedures) Order 2026. Its Schedule 1 covers cryolipolysis, HIFU, microneedling, non-ablative laser and light, and radiofrequency treatments. Electromagnetic muscle stimulation is not on that list. The most defensible reading is that NEO, which is a radiofrequency treatment as well as a muscle one, is the likelier of the two to fall inside the scheme, while the original EMSculpt sits outside it.
England has the same gap for different reasons: its proposed licensing tiers, published by the Department of Health and Social Care in August 2025, place radiofrequency treatments and hybrid devices in the middle tier but do not name muscle stimulation either, and that scheme is an England measure that is not yet in force.
Two practical consequences for a reader in Glasgow. First, the Care Quality Commission does not regulate you; where a clinic provides independent healthcare services in Scotland, those are registered with Healthcare Improvement Scotland instead. Second, as things stand in 2026, either device can lawfully be operated here by someone with no medical qualification. Ask who is holding the applicator and what they trained on, because at present nothing legal obliges them to tell you unprompted.
Cost, and the copies
Genuine branded treatment runs roughly £175 to £500 per session across UK clinics, with courses of four between about £995 and £3,400.
Well below that sits a large market of unbranded EMS body sculpting devices at £25 to £149 a session. These are not the machines used in any of the research above, and generally come with no published clinical data at all. A low price is the clearest signal that you are not buying the studied treatment.
Choosing between them
The honest summary is that NEO is the better evidenced of the two, and that the evidence for both is weaker than the marketing suggests. If your goal is fat reduction, only NEO has an indication supported by reviewed clinical data. If your goal is muscle definition and your fat layer is thin, the original device is targeting the thing you actually want, though the toning claim behind it was never clinically tested.
The exclusions also differ, and NEO’s are longer. Both rule out pacemakers, defibrillators, neurostimulators, electronic implants, drug pumps, metal implants, pregnancy, malignancy, fever and injured muscle. NEO’s radiofrequency adds cardiovascular disease, impaired temperature or pain perception, bleeding disorders, thyroid disease, a metallic coil, and treatment over a hernia. Our guide to who should not have EMSculpt goes through the full screening list.
If you want a straight answer about whether either version of EMSculpt suits your body and your goal, our practitioners at our Glasgow clinic will measure, explain what the evidence supports, and say so plainly when the answer is neither.
Frequently asked questions
Questions about emsculpt.
Is EMSculpt NEO simply EMSculpt with heat added?
Broadly yes, but the heat is the whole story. NEO delivers bipolar radiofrequency at 27.12 MHz through the same applicator at the same time as the electromagnetic field, warming the fat layer to roughly 40 to 45 degrees Celsius. That thermal component is why NEO holds a fat reduction indication and the original EMSculpt does not.
Is either device FDA approved?
No. Both are 510(k) cleared, which is a finding that a device is substantially equivalent to one already on the market, not a review of whether it works. US clearance also has no legal standing in the UK, where both are regulated as medical devices under the Medical Devices Regulations 2002. Registration status for these specific models could not be verified from a primary source, so treat any claim that they are MHRA approved with suspicion.
Does the original EMSculpt reduce fat?
It holds no fat indication anywhere in the manufacturer's portfolio. An independent study funded by a competing manufacturer took human biopsies after electromagnetic muscle stimulation and found no loss of fat cell viability and no inflammatory response, while cryolipolysis controls in the same study showed clear fat cell injury. That finding is contested rather than settled, but it is a reason to treat fat claims for HIFEM alone with caution.
Which of the two would suit me?
It largely depends on your subcutaneous fat layer. Electromagnetic stimulation alone works best when that layer is no more than about 2 to 3 cm, because the field weakens sharply with distance and thicker fat can produce weak or absent contractions. NEO is marketed up to a BMI of 35, though its upper arm clearance is capped at a BMI of 30. A consultation that measures rather than guesses is worth more than either brand name.
How long do the results last?
The longest published follow-up ran to a mean of 332.6 days, roughly 11 months, at which point measurable fat reduction and muscle increase remained. The NEO trial confirmed effects were held at six months. Beyond about 12 months there is no published data at all. Maintenance sessions at 8 to 12 months are suggested by manufacturer-aligned guidance, but no controlled evidence shows they extend results.
